Heather A. Berger

Insider Reports History

Entity
Individual
Location
C/O Entasis Therapeutics Holdings Inc., 35 Gatehouse Drive, Waltham, MA
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Heather A. Berger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Design Therapeutics, Inc. Director Common Stock 1.3K $4.87K $3.74 Mar 25, 2024 Direct
Design Therapeutics, Inc. Director Stock Option (right to buy) 19K Jun 13, 2024 Direct
Entasis Therapeutics Holdings Inc. Director Common Stock 0 $2.20 Jul 11, 2022 Direct
Entasis Therapeutics Holdings Inc. Director Stock Option (right to buy) 0 Jul 11, 2022 Direct

Insider Reports Filed by Heather A. Berger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DSGN Design Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
DSGN Design Therapeutics, Inc. Mar 25, 2024 1 $4.87K 4 Mar 25, 2024 Director
DSGN Design Therapeutics, Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
ETTX Entasis Therapeutics Holdings Inc. Jul 7, 2022 4 -$109K 4 Jul 11, 2022 Director
DSGN Design Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
ETTX Entasis Therapeutics Holdings Inc. Jan 18, 2022 1 $0 4 Jan 19, 2022 Director
ETTX Entasis Therapeutics Holdings Inc. Jul 16, 2021 4 $0 4 Feb 15, 2022 Director
DSGN Design Therapeutics, Inc. Jun 15, 2021 1 $0 4 Jun 16, 2021 Director
DSGN Design Therapeutics, Inc. Jun 15, 2021 0 $0 3 Jun 16, 2021 Director